CN104379154A - 骨折和骨质疏松防治方法和药物 - Google Patents
骨折和骨质疏松防治方法和药物 Download PDFInfo
- Publication number
- CN104379154A CN104379154A CN201280074010.9A CN201280074010A CN104379154A CN 104379154 A CN104379154 A CN 104379154A CN 201280074010 A CN201280074010 A CN 201280074010A CN 104379154 A CN104379154 A CN 104379154A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- treatment
- osteoporosis
- drug
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012115653/15A RU2498811C1 (ru) | 2012-04-19 | 2012-04-19 | Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей |
| RU2012115653 | 2012-04-19 | ||
| PCT/RU2012/000689 WO2013157984A1 (ru) | 2012-04-19 | 2012-08-21 | Препарат и способ профилактики и лечения остеопороза и переломов костей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104379154A true CN104379154A (zh) | 2015-02-25 |
Family
ID=49383802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280074010.9A Pending CN104379154A (zh) | 2012-04-19 | 2012-08-21 | 骨折和骨质疏松防治方法和药物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150174176A1 (enExample) |
| EP (1) | EP2875820A4 (enExample) |
| JP (1) | JP6286418B2 (enExample) |
| CN (1) | CN104379154A (enExample) |
| AU (1) | AU2012377478B2 (enExample) |
| BR (1) | BR112014025973B1 (enExample) |
| CA (1) | CA2870828C (enExample) |
| EA (1) | EA026534B1 (enExample) |
| IL (1) | IL235171B (enExample) |
| IN (1) | IN2014DN09779A (enExample) |
| RU (1) | RU2498811C1 (enExample) |
| UA (1) | UA111280C2 (enExample) |
| WO (1) | WO2013157984A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2549461C2 (ru) * | 2013-01-11 | 2015-04-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для лечения артритов и артрозов |
| RU2548776C2 (ru) * | 2013-01-11 | 2015-04-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для ускорения консолидации переломов костей |
| RU2564111C9 (ru) * | 2013-07-03 | 2016-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа |
| RU2593018C1 (ru) * | 2015-10-28 | 2016-07-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ лечения остеоартроза |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168273A (zh) * | 1997-07-24 | 1997-12-24 | 薛大权 | 蜂蛹钙制剂 |
| CN101951919A (zh) * | 2008-02-13 | 2011-01-19 | 帝斯曼知识产权资产管理有限公司 | 维生素d3和25-羟基-维生素d3用于治疗骨质疏松症和改善骨矿物质密度的组合用途 |
| RU2412616C1 (ru) * | 2009-11-30 | 2011-02-27 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики заболеваний остеопорозом |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743596A (en) * | 1987-06-16 | 1988-05-10 | Lapin Alfred R | Anti-arthritic preparation |
| EP1314427A4 (en) * | 2000-08-17 | 2006-05-03 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT FOR THE TREATMENT OF OSTEOPOROSIS |
| MXPA05013115A (es) * | 2003-06-06 | 2006-05-25 | Wyeth Corp | Metodos y materiales para identificar agentes que modulan la remodelacion de hueso y agentes identificados por los mismos. |
| FR2945748A1 (fr) * | 2009-05-20 | 2010-11-26 | Debregeas Et Associes Pharma | Medicament a base de calcium et de vitamine d. |
| RU2466732C1 (ru) * | 2011-05-31 | 2012-11-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ заполнения полостных образований в метафизарных (трабекулярных) участках костей кальцием и предотвращения выведения из них кальция |
| RU2497533C1 (ru) * | 2012-04-19 | 2013-11-10 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме) |
-
2012
- 2012-04-19 RU RU2012115653/15A patent/RU2498811C1/ru active
- 2012-08-21 CN CN201280074010.9A patent/CN104379154A/zh active Pending
- 2012-08-21 EA EA201401157A patent/EA026534B1/ru unknown
- 2012-08-21 AU AU2012377478A patent/AU2012377478B2/en active Active
- 2012-08-21 JP JP2015506935A patent/JP6286418B2/ja not_active Expired - Fee Related
- 2012-08-21 US US14/395,482 patent/US20150174176A1/en active Pending
- 2012-08-21 UA UAA201412409A patent/UA111280C2/uk unknown
- 2012-08-21 BR BR112014025973-9A patent/BR112014025973B1/pt active IP Right Grant
- 2012-08-21 WO PCT/RU2012/000689 patent/WO2013157984A1/ru not_active Ceased
- 2012-08-21 EP EP12874726.8A patent/EP2875820A4/en not_active Withdrawn
- 2012-08-21 CA CA2870828A patent/CA2870828C/en active Active
-
2014
- 2014-10-19 IL IL235171A patent/IL235171B/en active IP Right Grant
- 2014-11-19 IN IN9779DEN2014 patent/IN2014DN09779A/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168273A (zh) * | 1997-07-24 | 1997-12-24 | 薛大权 | 蜂蛹钙制剂 |
| CN101951919A (zh) * | 2008-02-13 | 2011-01-19 | 帝斯曼知识产权资产管理有限公司 | 维生素d3和25-羟基-维生素d3用于治疗骨质疏松症和改善骨矿物质密度的组合用途 |
| RU2412616C1 (ru) * | 2009-11-30 | 2011-02-27 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики заболеваний остеопорозом |
Non-Patent Citations (1)
| Title |
|---|
| 张石革: ""骨质疏松的药物治疗监护"", 《中国医药报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EA201401157A1 (ru) | 2015-05-29 |
| US20150174176A1 (en) | 2015-06-25 |
| IL235171B (en) | 2019-09-26 |
| AU2012377478A8 (en) | 2014-12-18 |
| BR112014025973B1 (pt) | 2021-09-28 |
| UA111280C2 (uk) | 2016-04-11 |
| CA2870828C (en) | 2019-01-15 |
| EA026534B1 (ru) | 2017-04-28 |
| EP2875820A1 (en) | 2015-05-27 |
| RU2498811C1 (ru) | 2013-11-20 |
| CA2870828A1 (en) | 2013-10-24 |
| WO2013157984A1 (ru) | 2013-10-24 |
| IN2014DN09779A (enExample) | 2015-07-31 |
| AU2012377478B2 (en) | 2017-07-06 |
| JP6286418B2 (ja) | 2018-02-28 |
| EP2875820A4 (en) | 2016-01-27 |
| JP2015514755A (ja) | 2015-05-21 |
| BR112014025973A2 (pt) | 2017-06-27 |
| AU2012377478A1 (en) | 2014-12-11 |
| IL235171A0 (en) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yarom et al. | Systematic review of natural agents for the management of oral mucositis in cancer patients | |
| EP3536381A1 (en) | Biologically active food supplement for use in preventing osteoporosis | |
| CN104736161B (zh) | 预防和治疗非典型性骨质疏松的制剂和方法 | |
| CN104379154A (zh) | 骨折和骨质疏松防治方法和药物 | |
| JP2015516974A5 (ja) | 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤 | |
| AU2017203767B2 (en) | Method for filling bone cavity formations with calcium | |
| CN105380031A (zh) | 一种保健食品及其制备方法 | |
| US20080241277A1 (en) | Herbal formulation for the treatment of bone fractures and osseous defects | |
| RU2585108C1 (ru) | Композиция для восстановления хрящевой и костной ткани при остеопорозе | |
| RU2601112C1 (ru) | Способ восстановления хрящевой и костной ткани при остеопорозе | |
| US20180193312A1 (en) | Nutraceutical composition and dosing regimen | |
| RU2282445C1 (ru) | Способ коррекции вегетативных проявлений климактерического синдрома у женщин с ишемическими нарушениями мозгового кровообращения | |
| Zujkina et al. | The pharmacotechnological studies of the phytospecies composition for the complex therapy of mastopathy | |
| Urankar et al. | Formulation development and evaluation of cholecalciferol (vitamin D3) granules and tablets | |
| US20190381072A1 (en) | Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis | |
| EP1938825B1 (de) | Einsatz von natürlichem Zeolith in der Therapie und Prophylaxe der Osteoporose | |
| CN117297083A (zh) | 一种预防骨质疏松症的生物活性食品增补剂 | |
| NZ619215B2 (en) | Method for filling bone cavities with calcium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150225 |
|
| RJ01 | Rejection of invention patent application after publication |